Henan Cancer Hospital: Stomach Neoplasms trials

The registry lists 13 Stomach Neoplasms studies with Henan Cancer Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 8No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerRecruitingNCT07334431Phase 1/2
• Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 OverexpressionNot yet recruitingNCT06227325Phase 2
• Toripalimab Plus FLOT in Locally Advanced Gastric CancerRecruitingNCT04891016Phase 2
• A Study on the Potential Benefit of Neoadjuvant Therapy for AGC PatientsStatus unknownNCT05442138
• RC48 Plus AK105 and Cisplatin in Advanced Gastric CancerStatus unknownNCT05313906Phase 2
• Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric CancerActive, not recruitingNCT05177068Phase 2
• Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric AdenocarcinomaStatus unknownNCT04948125Phase 2
• TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
• Study of CT and MR in the Gastric CancerStatus unknownNCT04028375
• Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 TypeStatus unknownNCT03963193Phase 2
• Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric CancerStatus unknownNCT03954756Phase 2
• A Real World Study of Apatinib in Treatment of Patients With Gastric CarcinomaStatus unknownNCT03735511
• The Real World Study of Apatinib for Gastric Cancer Treatment in Henan ProvinceStatus unknownNCT03478943